PATENT CLAIM ANALYSIS

Application Number: 16200508
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "044000"]

Abstract:
Treatment of tumors, especially breast cancer or glioblastoma tumors, by silencing RAB27A and/or TRAF3IP2, compositions and methods for same.

Claim (Index 19):
The method of  claim 16 , wherein said silencer(s) is encoded in an expression vector having an inducible promoter, thus enhancing the selective effect on tumor cells and avoiding effects on normal cells by selectively activating the production of the silencer by a switch that activates said inducible promoter.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 98.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14814130', '12792413', '14367926', '14239120', '14919448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7223386286893938
- 35 USC 102 Novelty (BERT): 0.6263005241780906
- Combined Prediction Score: 0.7127348182382635
- Mean Citation Score: 351.342546
- Max Citation Score: 704.4082599999997
- Similarity Product: 476.9478231314634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test